Esketamine treating depression #depression

Esketamine nasal spray shows promise for treating treatment-resistant depression, with higher remission and lower relapse rates compared to extended-release quetiapine. This could potentially revolutionize current treatment approaches.

Join this channel to get access to perks:
@medzcool

DISCLAIMER
⚠️ For Healthcare Practitioners: This content is provided only for medical education. Although the authors have made every effort to provide the most up-to-date, evidence-based medical information, this content should not necessarily be considered the standard of care. It may not reflect individual practices in other geographic locations. It should be considered in the context of other medical educational resources.
⚠️ For the Public: This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. You should contact your own physician or other qualified healthcare providers with any questions you may have regarding your medical condition. Do not disregard professional medical advice or delay seeking it based on information from this content. Relying on information provided in this content is done at your own risk. In a medical emergency, contact your physician or call 9-1-1 immediately.